Leveraging cutting-edge in vivo pharmacology solutions can be the key to unlocking breakthroughs in drug discovery in oncology and immuno-oncology. Pharmaron’s expertise, spanning over 1,700 annual oncology studies, includes patient-derived xenograft models, syngeneic models, and advanced humanized models, which enable accurate evaluation of drug efficacy and immune response. Our approach emphasizes precision, speed, and reproducibility, ensuring your therapeutic candidates are tested under rigorous conditions to deliver reliable, actionable results.

This brochure highlights the comprehensive capabilities that Pharmaron offers, including:

• A robust library of 1,700+ tumor models tailored to address diverse cancer research needs.
• Unmatched turnaround times, with studies initiated within 24 hours of order placement.
• Cutting-edge technologies like advanced imaging and in-depth immune profiling to enhance data clarity and decision-making.

Explore how Pharmaron can support your research and accelerate your path to clinical translation. Download the brochure today to discover the tools and expertise that set us apart.